These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25187730)

  • 1. Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis.
    Dookie N; Sturm AW; Moodley P
    Infect Drug Resist; 2014; 7():223-8. PubMed ID: 25187730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
    Naidoo CC; Pillay M
    J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
    Willby M; Sikes RD; Malik S; Metchock B; Posey JE
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5427-34. PubMed ID: 26100699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant
    Hameed HMA; Tan Y; Islam MM; Guo L; Chhotaray C; Wang S; Liu Z; Gao Y; Tan S; Yew WW; Zhong N; Liu J; Zhang T
    J Thorac Dis; 2019 Nov; 11(11):4613-4625. PubMed ID: 31903250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.
    Pillay M; Sturm AW
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):223-30. PubMed ID: 20074415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
    Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
    J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.
    Li J; Gao X; Luo T; Wu J; Sun G; Liu Q; Jiang Y; Zhang Y; Mei J; Gao Q
    Emerg Microbes Infect; 2014 Mar; 3(3):e19. PubMed ID: 26038513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S; Willby M; Sikes D; Tsodikov OV; Posey JE
    PLoS One; 2012; 7(6):e39754. PubMed ID: 22761889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
    Poissy J; Aubry A; Fernandez C; Lott MC; Chauffour A; Jarlier V; Farinotti R; Veziris N
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4765-71. PubMed ID: 20805388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion to and invasion of pulmonary epithelial cells by the F15/LAM4/KZN and Beijing strains of Mycobacterium tuberculosis.
    Ashiru OT; Pillay M; Sturm AW
    J Med Microbiol; 2010 May; 59(Pt 5):528-533. PubMed ID: 20110390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells.
    Mvubu NE; Pillay B; McKinnon LR; Pillay M
    Cytokine; 2018 Apr; 104():53-64. PubMed ID: 29032986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of
    Uddin MKM; Ather MF; Nasrin R; Rahman T; Islam ASMI; Rahman SMM; Ahmed S; Banu S
    Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
    Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.